Works matching IS 11750561 AND DT 2025 AND VI 26 AND IP 2

Results: 13

Real-World Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-23 Inhibitors: A Multicenter Retrospective Study: Real-World Experience of Bimekizumab for Plaque Psoriasis: S. Sood et al.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 2, p. 301, doi. 10.1007/s40257-025-00922-2

By:

Sood, Siddhartha;
Rimke, Alexander;
Rankin, Brian D.;
Abduelmula, Abrahim;
Georgakopoulos, Jorge R.;
Maliyar, Khalad;
Bagit, Ahmed;
Leung, Fernejoy;
Devani, Alim R.;
Vender, Ronald;
Yeung, Jensen;
Prajapati, Vimal H.

Publication type:

Article

Infections in Patients with Atopic Dermatitis and the Influence of Treatment: Recurrent Infections in Patients Treated for Atopic Dermatitis: M. Napolitano et al.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 2, p. 183, doi. 10.1007/s40257-025-00917-z

By:

Napolitano, Maddalena;
Esposito, Maria;
Fargnoli, Maria Concetta;
Girolomoni, Giampiero;
Romita, Paolo;
Nicoli, Elena;
Matruglio, Paolo;
Foti, Caterina

Publication type:

Article

Publisher Correction to: Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm: Multiple Keratoacanthomas Associated with Genetic Syndromes: A. Dobre et al.

Published in:

2025

By:

Dobre, Alexandra;
Nedelcu, Roxana-Ioana;
Turcu, Gabriela;
Brinzea, Alice;
Struna, Irina;
Tudorache, Gabriela;
Ali, Alen;
Hulea, Ionela;
Balasescu, Elena;
Fertig, Tudor Emanuel;
Gherghiceanu, Mihaela;
Harwood, Catherine;
Ion, Daniela Adriana;
Forsea, Ana-Maria

Publication type:

Correction Notice

Individualized Neoantigen-Directed Melanoma Therapy: Individualized Neoantigen-Directed Melanoma Therapy: K. Khaddour, E. I. Buchbinder.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 2, p. 225, doi. 10.1007/s40257-025-00920-4

By:

Khaddour, Karam;
Buchbinder, Elizabeth I.

Publication type:

Article

Safety of Hydroxychloroquine: What a Dermatologist Should Know: Hydroxychloroquine in Dermatological Practice: A Safety Assessment: L. Rapparini et al.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 2, p. 251, doi. 10.1007/s40257-025-00919-x

By:

Rapparini, Luca;
Cedirian, Stephano;
La Placa, Michelangelo;
Piraccini, Bianca Maria;
Raschi, Emanuel;
Starace, Michela

Publication type:

Article

The Impact of Family History on Clinical Presentation and Biologic Treatment Response in Patients with Psoriasis: A Multicenter Prospective Cohort Study: Family History and Biologic Treatment Efficacy in Psoriasis: Y. Jiang et al.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 2, p. 291, doi. 10.1007/s40257-025-00918-y

By:

Jiang, Yuxiong;
Liu, Xiaoke;
Ma, Rui;
Huang, Dawei;
Wang, Yu;
Zhong, Xiaoyuan;
Yao, Lingling;
Xu, Shuang;
Li, Ying;
Zhang, Xilin;
Lu, Jiajing;
Shi, Yuling

Publication type:

Article

Characterization of Clinicopathological Features and Autoantibody Profiles in Patients with Cutaneous Lupus Erythematous: A Single-Center Retrospective Study: Characterization of Clinicopathological Features and Autoantibody Profiles in CLE: S. Pazhyanur et al

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 2, p. 265, doi. 10.1007/s40257-024-00916-6

By:

Pazhyanur, Svati;
Lamberg, Olivia;
Hauptman, Megan;
Cristiu, Jessica;
Khan, Noreen;
Billi, Allison C.;
Nakamura, Mio

Publication type:

Article

Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea: Complex Landscape of Pityriasis Rosea: K. D. Mashoudy et al.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 2, p. 237, doi. 10.1007/s40257-024-00915-7

By:

Mashoudy, Kayla D.;
Kim, Sarah;
Farhadi, Leah;
Elman, Scott A.

Publication type:

Article

Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment: Biomarkers in Atopic Dermatitis: The Role of IL-13: J. Gorelick et al.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 2, p. 199, doi. 10.1007/s40257-024-00913-9

By:

Gorelick, Joe;
Nguyen, Andrea;
Schneider, Shannon K R;
Martel, Britta C.;
Madsen, Daniel E.;
Armstrong, April W.

Publication type:

Article

Frontal Fibrosing Alopecia: An Update: Frontal Fibrosing Alopecia: An Update: A. G. Messenger et al.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 2, p. 155, doi. 10.1007/s40257-024-00912-w

By:

Messenger, Andrew G.;
Asfour, Leila;
Harries, Matthew

Publication type:

Article

Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?: Hidradenitis Suppurativa and GLP-1 Receptor Agonists: J. Strong, Marcia S. Driscoll.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 2, p. 175, doi. 10.1007/s40257-024-00911-x

By:

Strong, Jennifer;
Driscoll, Marcia S.

Publication type:

Article

Prognostic Biomarkers in Evolving Melanoma Immunotherapy: Update: Biomarkers in Melanoma Immunotherapy: R. Reschke et al.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 2, p. 213, doi. 10.1007/s40257-024-00910-y

By:

Reschke, Robin;
Enk, Alexander H.;
Hassel, Jessica C.

Publication type:

Article

A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis: Ruxolitinib Cream: Pediatric Maximum-Use Trial: L. S. Gold et al.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 2, p. 275, doi. 10.1007/s40257-024-00909-5

By:

Stein Gold, Linda;
Bissonnette, Robert;
Forman, Seth;
Zaenglein, Andrea;
Kuo, YuTzu;
Angel, Brett;
Chen, Xuejun;
Kallender, Howard;
Paller, Amy S.

Publication type:

Article